AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
BLOOMINGTON, Ind., Nov. 11 (UPI) -- A common class of drugs prescribed to children with depression may have an adverse effect on bone growth, a study says.
Researchers at the Indiana University School of Medicine said they looked at the effect of selective serotonin-reuptake inhibitors, or SSRIs, on bone accrual in growing mice. The findings showed a reduction in bone mass and size in the mice administered an SSRI.
The study was outlined in the journal Endocrinology.
"These findings indicate a…